USD 0.03
(6.67%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 11.22 Million USD | -85.19% |
2022 | 75.8 Million USD | -24.35% |
2021 | 100.2 Million USD | 19.56% |
2020 | 83.81 Million USD | 29.19% |
2019 | 64.87 Million USD | 100.19% |
2018 | 32.4 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 2.22 Million USD | -119.3% |
2024 Q1 | 3.33 Million USD | 112.62% |
2023 Q1 | 15.68 Million USD | -0.22% |
2023 FY | 11.22 Million USD | -85.19% |
2023 Q3 | 12.22 Million USD | -23.98% |
2023 Q2 | 16.08 Million USD | 2.56% |
2023 Q4 | -26.44 Million USD | -316.28% |
2022 Q3 | 15.62 Million USD | -29.23% |
2022 Q2 | 22.07 Million USD | -1.38% |
2022 Q1 | 22.38 Million USD | -9.38% |
2022 FY | 75.8 Million USD | -24.35% |
2022 Q4 | 15.71 Million USD | 0.58% |
2021 FY | 100.2 Million USD | 19.56% |
2021 Q3 | 25.1 Million USD | 1.33% |
2021 Q4 | 24.7 Million USD | -1.59% |
2021 Q2 | 24.77 Million USD | -3.31% |
2021 Q1 | 25.62 Million USD | 6.2% |
2020 Q3 | 24.17 Million USD | 39.74% |
2020 Q2 | 17.3 Million USD | -4.98% |
2020 Q1 | 18.2 Million USD | 18.32% |
2020 FY | 83.81 Million USD | 29.19% |
2020 Q4 | 24.12 Million USD | -0.21% |
2019 Q1 | 8.47 Million USD | 0.0% |
2019 FY | 64.87 Million USD | 100.19% |
2019 Q4 | 15.38 Million USD | -46.65% |
2019 Q3 | 28.84 Million USD | 136.92% |
2019 Q2 | 12.17 Million USD | 43.73% |
2018 FY | 32.4 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Biotricity, Inc. | 17.18 Million USD | 34.686% |
Cell MedX Corp. | 313.43 Thousand USD | -3481.023% |
Dynatronics Corporation | 9.9 Million USD | -13.282% |
Nemaura Medical Inc. | 7.13 Million USD | -57.225% |
PetVivo Holdings, Inc. | 11.36 Million USD | 1.205% |
RetinalGenix Technologies Inc. | 2.08 Million USD | -437.793% |
Sonendo, Inc. | 68.46 Million USD | 83.606% |
Telesis Bio, Inc. | 63.48 Million USD | 82.321% |
Talis Biomedical Corporation | 67.18 Million USD | 83.294% |
Viveve Medical, Inc. | 22.17 Million USD | 49.38% |